Physician
Dermatology
Dr. Mary M. Morgan, MD
|
|
Give Review
Mary Morgan practices Dermatology. She graduated from Louisiana State University School of Medicine in Shreveport. She received 1 awards: "Fellow (FASDS)". Doctor Mary M. Morgan, MD is a published physician. She has 72 publications published. The most current publication "TCR, LFA-1, and CD28 play unique and complementary roles in signaling T cell cytoskeletal reorganization." She is registered with Medicare and accepts Medicare payments.
Publications
- Opioid receptor internalization contributes to dermorphin-mediated antinociception.
- Morphine preferentially activates the periaqueductal gray-rostral ventromedial medullary pathway in the male rat: a potential mechanism for sex differences in antinoci...
- Evidence for an intrinsic mechanism of antinociceptive tolerance within the ventrolateral periaqueductal gray of rats.
- Behavioral and electrophysiological evidence for tolerance to continuous morphine administration into the ventrolateral periaqueductal gray.
- Oestradiol dampens reflex-related activity of on- and off-Cells in the rostral ventromedial medulla of female rats.
- Behavioral evidence linking opioid-sensitive GABAergic neurons in the ventrolateral periaqueductal gray to morphine tolerance.
- Comparison of morphine and kainic acid microinjections into identical PAG sites on the activity of RVM neurons.
- Superantigen-induced T Cell:B Cell conjugation is mediated by LFA-1 and requires signaling through Lck, but not ZAP-70.
- Are technologists qualified to be educators? Point: technologists are not qualified to be educators.
- GAPS between MFT supervision assumptions and common practice: suggested best practices.
- Activation of the ventrolateral periaqueductal gray reduces locomotion but not mean arterial pressure in awake, freely moving rats.
- Tolerance to the antinociceptive effect of morphine microinjections into the ventral but not lateral-dorsal periaqueductal gray of the rat.
- TCR, LFA-1, and CD28 play unique and complementary roles in signaling T Cell cytoskeletal reorganization.
- Paradoxical inhibition of nociceptive neurons in the dorsal horn of the rat spinal cord during a nociceptive hindlimb reflex.
- Optimizing healthcare research data warehouse design through past COSTAR query analysis.
- Direct comparison of heat-evoked activity of nociceptive neurons in the dorsal horn with the hindpaw withdrawal reflex in the rat.
- Long-term changes in compliance with clinical guidelines through computer-based reminders.
- Multiple signaling pathways establish both the individuation and the polarity of the oocyte follicle in Drosophila.
- Characterization of stimulation-produced analgesia from the nucleus tractus solitarius in the rat.
- Intrathecal administration of pentobarbital and THIP: evidence for descending excitatory and inhibitory modulation of a spinal reflex.
- Do resident and staff physicians differ in the types and costs of antihypertensive drugs they select?
- Diazepam dissociates the analgesic and aversive effects of periaqueductal gray stimulation in the rat.
- Stimulation of the periaqueductal gray matter inhibits nociception at the supraspinal as well as spinal level.
- Diffuse noxious inhibitory controls reduce the expression of noxious stimulus-evoked Fos-like immunoreactivity in the superficial and deep laminae of the rat spinal cord.
- Involvement of the periaqueductal gray matter and serotonin in the analgesia produced by stimulation of the nucleus tractus solitarius.
- Barbiturate-induced inhibition of a spinal nociceptive reflex: role of GABA mechanisms and descending modulation.
- Dissociation of hyperalgesia from fever following intracerebroventricular administration of interleukin-1beta in the rat.
- Activity of neurons in the rostral medulla of the halothane-anesthetized rat during withdrawal from noxious heat.
- Site specificity in the development of tolerance to stimulation-produced analgesia from the periaqueductal gray matter of the rat.
- Stimulation of the periaqueductal gray matter of the rat produces a preferential ipsilateral antinociception.
- Analysis of opioid efficacy, tolerance, addiction and dependence from Cell culture to human.
- Periaqueductal gray stimulation produces a spinally mediated, opioid antinociception for the inflamed hindpaw of the rat.
- The sensitivity of medical diagnostic decision-support knowledge bases in delineating appropriate terms to document in the medical record.
- Activity of nociceptive modulatory neurons in the rostral ventromedial medulla associated with volume expansion-induced antinociception.
- Simultaneous analysis of the time course for changes in core body temperature, activity, and nociception following systemic administration of interleukin-1beta in the ...
- Identification of nocifensor reflex-related neurons in the rostroventromedial medulla of decerebrated rats.
- Early methylphenidate exposure enhances morphine antinociception and tolerance in Adult rats.
- Behavioral analysis of diffuse noxious inhibitory controls (DNIC): antinociception and escape reactions.
- GABAergic modulation of the analgesic effects of morphine microinjected in the ventral periaqueductal gray matter of the rat.
- The influence of non-nociceptive factors on hot-plate latency in rats.
- Immobility accompanies the antinociception mediated by the rostral ventromedial medulla of the rat.
- Immobility and flight associated with antinociception produced by activation of the ventral and lateral/dorsal regions of the rat periaqueductal gray.
- Repeated cannabinoid injections into the rat periaqueductal gray enhance subsequent morphine antinociception.
- Direct and indirect actions of morphine on medullary neurons that modulate nociception.
- Inhibition and facilitation of different nocifensor reflexes by spatially remote noxious stimuli.
- Circuitry linking opioid-sensitive nociceptive modulatory systems in periaqueductal gray and spinal cord with rostral ventromedial medulla.
- Morphine antinociceptive potency on chemical, mechanical, and thermal nociceptive tests in the rat.
- Antinociceptive tolerance to morphine from repeated nociceptive testing in the rat.
- Differential susceptibility of the PAG and RVM to tolerance to the antinociceptive effect of morphine in the rat.
- ExtraCellular signal-regulated kinase 1/2 activation counteracts morphine tolerance in the periaqueductal gray of the rat.
- Glutamate modulation of antinociception, but not tolerance, produced by morphine microinjection into the periaqueductal gray of the rat.
- Toward a common-factors approach to supervision.
- Pronounced changes in the activity of nociceptive modulatory neurons in the rostral ventromedial medulla in response to prolonged thermal noxious stimuli.
- Disinhibition of off-Cells and antinociception produced by an opioid action within the rostral ventromedial medulla.
- Microinjection of morphine into the rostral ventromedial medulla produces greater antinociception in male compared to female rats.
- PAG mu opioid receptor activation underlies sex differences in morphine antinociception.
- Drug dependent sex-differences in periaqueducatal gray mediated antinociception in the rat.
- Analgesic tolerance to microinjection of the micro-opioid agonist DAMGO into the ventrolateral periaqueductal gray.
- Antinociception mediated by the periaqueductal gray is attenuated by orphanin FQ.
- Antinociceptive tolerance revealed by cumulative intracranial microinjections of morphine into the periaqueductal gray in the rat.
- Behavioral and electrophysiological evidence for opioid tolerance in adolescent rats.
- Defensive behaviors evoked from the ventrolateral periaqueductal gray of the rat: comparison of opioid and GABA disinhibition.
- Tolerance to repeated microinjection of morphine into the periaqueductal gray is associated with changes in the behavior of off- and on-Cells in the rostral ventromedi...
- Behavioral consequences of delta-opioid receptor activation in the periaqueductal gray of morphine tolerant rats.
- Contribution of dopamine receptors to periaqueductal gray-mediated antinociception.
- Periaqueductal gray neurons project to spinally projecting GABAergic neurons in the rostral ventromedial medulla.
- Sexually dimorphic activation of the periaqueductal gray-rostral ventromedial medullary circuit during the development of tolerance to morphine in the rat.
- Microinjection of the vehicle dimethyl sulfoxide (DMSO) into the periaqueductal gray modulates morphine antinociception.
- Tolerance to repeated morphine administration is associated with increased potency of opioid agonists.
- Intermittent dosing prolongs tolerance to the antinociceptive effect of morphine microinjection into the periaqueductal gray.
- Tolerance to the antinociceptive effect of morphine in the absence of short-term presynaptic desensitization in rat periaqueductal gray neurons.
Schools
Louisiana State University School Of Medicine In Shreveport
Louisiana State University Medical Center Hospital
University Iowa Hosps and Clins
Oklahoma State University
Procedures Preformed
- Chemical Peel
- Cosmetic Laser Surgery
- Destruction of Benign Skin Lesion
- Excision of Benign Skin Lesion
- View All
Conditions Treated
- Acne Vulgaris
- Actinic Keratosis
- Adult Acne
- Athlete's Foot
- View All
Doctors Specialties
- Cosmetic Dermatology
- Dermatologic Surgery
- Dermatology
Accepted Insurances
Awards
- Fellow (FASDS)
Education
-
Louisiana State University -
University of Iowa Hospitals and Clinics -
Louisiana State University School of Medicine in Shreveport
Drug Facts
| NPI NUMBER | 1487621413 | |
| NPPES Provider LastName | MORGAN | |
| NPPES Provider FirstName | MARY | |
| NPPES Provider ZIPCode | 740125940 | |
| NPPES Provider State | OK | |
| Specialty Description | Dermatology | |
| Total Claim Count | 75.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1487621413 |
| Last Name Of The Provider | MORGAN |
| First Name Of The Provider | MARY |
| View All |
Similar Doctors
|
|
Dr. Martha M. Robinson, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kevin J. Gaddis, MD |